Nuveen Asset Management LLC grew its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 34.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 422,475 shares of the company's stock after acquiring an additional 107,695 shares during the period. Nuveen Asset Management LLC owned about 0.11% of LifeStance Health Group worth $3,114,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of LifeStance Health Group by 2.4% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock valued at $1,023,000 after acquiring an additional 3,305 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in shares of LifeStance Health Group by 51.4% in the fourth quarter. Janus Henderson Group PLC now owns 59,500 shares of the company's stock valued at $439,000 after acquiring an additional 20,200 shares in the last quarter. D. E. Shaw & Co. Inc. purchased a new stake in shares of LifeStance Health Group in the fourth quarter valued at about $451,000. Deutsche Bank AG boosted its holdings in shares of LifeStance Health Group by 78.8% in the fourth quarter. Deutsche Bank AG now owns 120,163 shares of the company's stock valued at $886,000 after acquiring an additional 52,970 shares in the last quarter. Finally, Bank of America Corp DE boosted its holdings in shares of LifeStance Health Group by 30.1% in the fourth quarter. Bank of America Corp DE now owns 396,662 shares of the company's stock valued at $2,923,000 after acquiring an additional 91,796 shares in the last quarter. Hedge funds and other institutional investors own 85.50% of the company's stock.
Insider Buying and Selling at LifeStance Health Group
In other LifeStance Health Group news, insider Lisa K. Miller sold 18,845 shares of the company's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the sale, the insider now owns 339,810 shares of the company's stock, valued at $2,344,689. This represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 3.20% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms recently commented on LFST. UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price objective on the stock in a report on Tuesday, May 27th. KeyCorp began coverage on shares of LifeStance Health Group in a report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price objective on the stock. Canaccord Genuity Group began coverage on shares of LifeStance Health Group in a report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price objective on the stock. Finally, William Blair reissued an "outperform" rating on shares of LifeStance Health Group in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, LifeStance Health Group presently has an average rating of "Moderate Buy" and a consensus target price of $8.50.
Read Our Latest Report on LFST
LifeStance Health Group Price Performance
Shares of NASDAQ LFST traded down $0.02 on Thursday, hitting $5.93. The company's stock had a trading volume of 1,350,248 shares, compared to its average volume of 1,597,152. LifeStance Health Group, Inc. has a 12-month low of $4.64 and a 12-month high of $8.61. The company has a market capitalization of $2.31 billion, a price-to-earnings ratio of -22.81 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The stock has a 50 day moving average of $6.26 and a 200-day moving average of $7.09.
About LifeStance Health Group
(
Free Report)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Further Reading
Before you consider LifeStance Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.
While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
